Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC33A1 | O00400 | 13/20 | 0.40 |
| ▸ | APLNR | P35414 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.34 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12348768 | 0.90 | SLC33A1 (0.37) | SLC33A1APLNR | |
| SCHEMBL1890017 | 0.79 | SLC33A1 (0.38) | SLC33A1APLNRAGTR1ACHE | |
| SCHEMBL1892295 | 0.79 | SLC33A1 (0.39) | SLC33A1APLNRAGTR1ACHE | |
| SCHEMBL1892845 | 0.79 | APLNR (0.40) | APLNR | |
| SCHEMBL1889496 | 0.77 | APLNR (0.38) | SLC33A1APLNR | |
| SCHEMBL4013436 | 0.77 | SLC33A1 (0.40) | SLC33A1 | |
| SCHEMBL4011164 | 0.73 | SLC33A1 (0.39) | SLC33A1APLNR | |
| SCHEMBL1893594 | 0.73 | SLC33A1 (0.40) | SLC33A1 | |
| SCHEMBL1887534 | 0.72 | SLC33A1 (0.41) | SLC33A1AGTR1ACHE | |
| SCHEMBL12348764 | 0.71 | SLC33A1 (0.38) | SLC33A1AGTR1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009133970-A1 | CRYSTALLINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-11-05 | — | — | WO | disclosed |